Clinical Trial Update: HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery [NA]

View source ↗

Summary

The HISMAR trial assesses whether intraoperative margin assessment using the Histolog scanner can reduce reoperations after breast-conserving surgery in breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Invasive Lobular Carcinoma

Snippet

Sponsor: Hôpital du Valais | Conditions: Breast Cancer, Ductal Carcinoma In Situ | NA | Status: NOT_YET_RECRUITING